Page results
-
This page has been written for patients who are having radioactive iodine (131I) ablation and/or radioiodine treatment for thyroid cancer.
-
The National Paediatric Diabetes Audit (NPDA) is asking all children and young people (8-19 years) and parents/carers (of children under 8 years old) who have received diabetes care in the past 6 months, to fill in the survey.
-
The special haematology service provides a comprehensive investigation of haemolytic amaemia, haemoglobinopathies and red cell enzymopathy.
-
This page is for patients with obesity who are waiting for scheduled surgery.
-
How UCLH uses clinical data in research.
-
Information for service users about the RESPOND service for refugees and asylum seekers.
-
Fears that people with high blood pressure are more at risk from severe Covid-19 because it is easier for the virus to enter their cells and tissues have been laid to rest, thanks to research involving UCLH.
-
A new CAR T-cell therapy developed by scientists at UCL has fewer ‘toxic’ side-effects and is more durable, targeting and killing cancer cells for longer, concludes a Phase 1 clinical trial of patients at UCLH.
-
One of our patients who is recovering from COVID-19 has been appearing across national media as she recounts her story and thanks the staff who saved her life.
-
This information explains brain stem death and the tests used to confirm the diagnosis. It aims to answer frequently asked questions.
File results
-
FOI/2023/0019 - Public access to water refill stations on your premises
-
FOI/2023/0022 - Guidelines staff follow for patients with disabilities and autism
-
FOI/2023/0025 - Treatment for multiple sclerosis
-
FOI/2023/0027 - Dieticians and Nutritionists at the RLHIM
-
FOI/2023/0034 - Trusts video consultation solutions
-
FOI/2023/0025 - Surgical operating tables used in Trust
-
FOI/2023/0037 - Assault attendances to Emergency Department
-
FOI/2023/0038 - Cases where breast milk of a new mother was given to a child who is not her own
-
FOI/2023/0041 - International recruitment
-
FOI/2023/0054 - Local formulary used at the Trust